The role of vitamin D beyond its classical function in calcium homeostasis has been of significant interest in recent years. There has been expanding research on the pleiotropic role of vitamin D in pregnancy and the implications of its deficiency on maternal-fetal outcomes. Several studies have associated low maternal vitamin D status to adverse outcomes in pregnancy, including preeclampsia, gestational diabetes, preterm births, low birth weight, and others. Several randomized controlled clinical trials of Vitamin D supplementation during pregnancy have also been conducted. Though some of the studies found improvement in pregnancy outcomes with vitamin D supplementation, others have not shown any association. In this article, we have critically reviewed the observational and interventional studies, published primarily within the past two years (January 2014 to February 2016) on the influence of vitamin D deficiency on pregnancy and the impact of its supplementation. The potential underlying mechanisms of vitamin D in regulating each of the outcomes have also been discussed.
Introduction
Vitamin D is a secosteroid, which is also considered an important prohormone (Weinert and Silveiro, 2015) . Since vitamin D receptors (VDRs) are present in many cells and tissues throughout the body, many studies support the role of vitamin D in several physiological functions beyond bone and muscle health (Joergensen et al., 2014) . During pregnancy, vitamin D plays a vital role in embryogenesis, especially fetal skeletal development and calcium homeostasis (Hollis et al., 2011) . Vitamin D deficiency is a growing health concern worldwide in both adults and children (Weinert and Silveiro, 2015) . Indeed, the findings from several studies suggest the increasing prevalence of vitamin D deficiency in pregnancy and the associated adverse maternal and fetal outcomes, such as gestational diabetes mellitus (GDM), preeclampsia, small for gestational age (SGA), preterm births among others (Palaniswamy et al., 2016) ( Figure 1) .
To further investigate the role of vitamin D in pregnancy and the improvement of outcomes on its supplementation, many interventional and observational studies have been undertaken but the results have not been consistent. Heterogeneity in the findings could be attributed, but not limited, to the differences in ethnicity, geographical locations, amount of vitamin D supplementation, and duration of supplementation. The methodology of the studies is not consistent and cannot be compared since the studies were conducted at different stages of gestation. It is still not well defined as to how vitamin D supplementation modifies the risk of the outcomes and whether vitamin D contributes to the etiopathogenesis of these diseases or it is just a marker (Yin and Agrawal, 2014) . Given the low cost of vitamin D supplementation, if proven effective in pregnancy, it could bring about some major improvements in public health worldwide (Christesen et al., 2012) .
The impact of vitamin D deficiency during pregnancy has been discussed in a few recent reviews and meta analyses (Harvey et al., 2014; P erez-L opez et al., 2015; Wei and Christakos, 2015) ; however, more randomized clinical trials (RCTs) and observational studies have been conducted after the publication of the last review. Hence, this review article summarizes the recent studies on the influence of vitamin D deficiency during pregnancy. The impact of vitamin D supplementation on various maternal and fetal clinical endpoints has also been reviewed with critical discussion on the clinical and translational application of these findings and identified gaps in our knowledge to conduct future prospective studies. studies of interest included original articles and review articles on the influence of vitamin D deficiency in pregnancy and the impact of vitamin D supplementation on the maternal and fetal outcomes. References in these articles were searched for any other related articles. Duplicate articles were excluded. Articles were also excluded if they were not published in English language; were unavailable in full text, or if the studies did not involve human subjects. Sixty studies fit the criteria and hence, were critically evaluated in this review.
Physiology of vitamin D and vitamin D deficiency
Vitamin D is a fat-soluble vitamin with two major physiological forms: Ergocalciferol, vitamin D2, and Cholecalciferol vitamin D3 (DeLuca, 2014) . These two forms basically differ in their side chain structure. While D2 is mainly obtained from plants and vegetable sources, D3 is majorly synthesized in the skin on exposure to sunlight (UVB radiation) from 7 dehydrocholesterol (De-Regil et al., 2016) . Both forms of vitamin D are also available as dietary supplements. All the forms of vitamin D are activated only on enzyme-mediated hydroxylation. The first hydroxylation reaction is mediated by 25a-hydroxylase, to produce 25 hydroxyvitamin D (25OHD) or calcidiol and takes place in the liver (Harvey et al., 2014) . This is followed by the next hydroxylation step in the kidney, mediated by 1a-hydroxylase, to produce 1, or calcitriol (Wagner et al., 2015) . While 25OHD is the most abundant circulating form of vitamin D, 1,25-DHCC is the most active form. The hydroxylation reactions and the availability of active vitamin D are regulated by serum calcium and phosphorus and parathyroid hormone (PTH; Lips, 2006) .
Apart from its critical role in the regulation of calcium and phosphorus homeostasis for skeletal development, vitamin D also mediates other functions, including anti-inflammation, regulation of innate and acquired immunity, and prevention of cardiovascular diseases (Christakos et al., 2016) .
Based on the recommendations by the Institute of Medicine (IOM), the recommended daily intake of vitamin D during pregnancy and lactation is 600 IU, taking into account the fetal demands as well (Grant and Alistair, 2014) . The serum 25OHD is regarded as the best stable and circulating biomarker for vitamin D status (Brannon and Picciano, 2011) . The cut-off value for vitamin D deficiency is set at 20 ng/ml while for vitamin D insufficiency it ranges from 20 to 30 ng/ml (Ross et al., 2011) .
Vitamin D deficiency is a global epidemic affecting people of all age groups with the principal cause being the lack of exposure to sunlight (Holick and Chen, 2008) . Others include darker skin (high melanin content), aging, use of sunscreen, and winters, all associated with decreased dermal synthesis of vitamin D (Holick and Chen, 2008) . Some pathological conditions associated with low vitamin D include kidney failure, intestinal malabsorption, chronic inflammation and liver failure, and use of concurrent medications (Dusilov a-Sulkov a, 2009). As a consequence, there is decreased bone density and greater susceptibility to fractures. Children suffer from rickets, while adults develop osteopenia or osteoporosis. Additionally, vitamin D deficiency is also associated with other co-morbid conditions like type 1 diabetes mellitus, neoplasms, cardiovascular diseases, and others (Dusilov a-Sulkov a, 2009).
Vitamin D in pregnancy
During pregnancy, mobilization of maternal calcium increases to meet the demands of adequate fetal bone mineralization (Olmos-Ortiz et al., 2015) . As a consequence, a number of physiological adaptations take place, including increased maternal serum calcitriol, vitamin D binding protein (DBP), placental VDR, and renal and placental CYP27B1 activity to maintain normal serum levels of 25OHD and calcium (Olmos-Ortiz et al., 2015) . Maternal 25OHD crosses the placenta and is the main form of vitamin D for the fetus (Marshall et al., 2013) . Calcitriol rises during pregnancy, almost doubled by the end of third trimester and then returns to normal levels after delivery ( Marshall et al., 2013) . During pregnancy, even placenta and fetal kidney express 1a-hydroxylase stimulated by prolactin and placental lactogen, though the major function is still performed by the maternal renal hydroxylase (Olmos-Ortiz et al., 2015) . Maternal serum calcium levels fall during pregnancy, which can be attributed to a decrease in the serum albumin, but the ionized calcium levels remain unchanged (Olausson et al., 2012) . In fact, fetal serum calcium levels are higher than maternal serum calcium levels, thereby requiring specific transplacental carriers to transfer calcium against the concentration gradient (Olmos-Ortiz et al., 2015) . This is mediated by the expression of calcium binding proteins in placenta, including calbindin D-9k and D-28k (Halhali et al., 2010) .
The most important contribution of vitamin D during pregnancy is to escalate calcium absorption and placental calcium transport (Olmos-Ortiz et al., 2015) . Additionally, vitamin D also regulates immune system and inhibits inflammation by restraining inflammatory cytokines including TNF-a, IFN-g, IL-6, while promoting the release of antimicrobial peptide cathelicidin hCTD in the placenta (Olmos-Ortiz et al., 2015) . Calcitriol also plays an important role in placental physiology. It stimulates endometrial decidualization, synthesis of estradiol and progesterone, and regulation of the expression of human chorionic gonadotrophin (hCG) and human placental lactogen (hPL) in the placenta (Olmos-Ortiz et al., 2015) .
All these effects indicate the vital importance of vitamin D during gestation and the potential role of its deficiency on adverse maternal-fetal outcomes ( Figure 2 ). Each maternal and fetal outcome investigated in the recent articles has been discussed in detail below with a tabular representation of the recent observational studies in Tables 1 and 2. The impact of vitamin D supplementation has also been reviewed with a depiction of the recent Randomized Controlled Trials shown in Table 3 . Table 4 summarizes the level of evidence of the impact of vitamin D on various maternal-fetal outcomes based on the GRADE system.
Adverse maternal outcomes associated with vitamin D deficiency

Preeclampsia
Preeclampsia is defined as newly diagnosed hypertension (systolic blood pressure >140 mmHg, diastolic blood pressure >90 mmHg) after 20 weeks of gestation along with proteinuria (>300 mg/day), and other organ dysfunction, including liver involvement, hematological disturbance, neurological, or renal complications (Roberts et al., 2016) . Pathogenesis is related to the release of angiogenic factors into maternal circulation, which causes inadequate remodeling and trophoblastic invasion of spiral arteries, and consequently shallow implantation and hypoxia, and even release of inflammatory mediators (Singla et al., 2015; Sircar et al., 2015) . The protective role of vitamin D in preeclampsia can be explained by multiple mechanisms. One of them is the immunomodulatory role of calcitriol in regulating immune response. Defective control of effector T cells by regulatory T cells can lead to poor placental invasion, thereby leading to the release of placenta-derived vasoconstrictive factors, and consequently maternal hypertension and proteinuria (Hypp€ onen et al., 2013) . Vitamin D helps in maintaining the immune homeostasis and thus prevents placental vasoconstriction and ultimately, preeclampsia (Hypp€ onen et al., 2013) . Also, vitamin D regulates the endothelial and vascular smooth muscle cell proliferation and therefore, plays a role in regulating blood pressure through RAAS (Renin-Angiotensin-Aldosterone system) (Hypp€ onen et al., 2013) . Vitamin D has also been found to regulate angiogenesis via its receptor elements in VEGF promoter and stimulating the expression of VEGF in vascular smooth muscle cells. Calcitriol also helps to prevent cholesterol uptake by the macrophages and vascular smooth muscle cells of the arterial walls, which is the observed pathology in utero placental vessels of patients with preeclampsia (Hypp€ onen et al., 2013) . Despite these findings, in other studies no causal relationship was found between Figure 2 . The schematic diagram depicts the activation of vitamin D by two hyroxylation steps, one each in liver and kidney, followed by the normal physiological role of vitamin D in each organ. The specific maternal and fetal repercussion of vitamin D deficiency are mentioned below the dotted line. vitamin D supplementation and improvement/prevention of preeclampsia. These studies are discussed below. Several observational studies were recently performed to investigate an association between vitamin D deficiency and preeclampsia but the findings have been inconsistent. Eleven observational studies have examined the association between preeclampsia and vitamin D; Achkar et al. (2015) carried out a nested case-control study in Canada and concluded that vitamin D deficiency (<30 ng/ml) was associated with increased risk of preeclampsia (adjusted Odd's Ratio (OR), 2.23; 95% Confidence Interval (CI) 1.29-3.83). Similar results were also reported by other recent studies (Abedi et al., 2014; Mohaghegh et al., 2015; Sadin et al., 2015; Singla et al., 2015) . On the contrary, Bomba-Opon et al. (2014) measured the 25OHD levels in 280 pregnant women in Poland and found no association between vitamin D levels and markers of preeclampsia, including Pregnancy-associated plasma protein A (PAPP-A), Placenta Growth Factor (PlGF), uterine artery pulsatility index, and mean arterial pressure. Similarly, Schneuer et al. (2014) reported no increased risk of preeclampsia in vitamin D deficient pregnant women in a nested case-control study conducted in 5109 pregnant women. Some other studies also described comparable outcomes (Burris et al., 2014; Wetta et al., 2014; Gidl€ of et al., 2015; van Weert et al., 2016) .
Many randomized controlled trials (RCT) have been undertaken to determine the impact of vitamin D supplementation in preeclampsia patients. In the past two years, three of the investigations took place in Iran (Asemi and Esmaillzadeh, 2015; Mojibian et al., 2015; Samimi et al., 2016) and one each in India (Sablok et al., 2015) and Pakistan (Hossain et al., 2014) . Positive impact was found in some (Asemi and Esmaillzadeh, 2015; Sablok et al., 2015; Samimi et al., 2015) while no significant impact was reported in others (Hossain et al., 2014) . Similarly, Karamali et al. (2015) conducted a double blind placebo-controlled RCT in pregnant women at risk of preeclampsia determined by abnormal uterine artery waveform, and reported no significant change in blood pressure with vitamin D supplementation. When combined supplementation of vitamin D and calcium was given in an interventional study to atrisk preeclampsia patients, significant improvement in the outcomes with reduced systolic and diastolic blood pressure was observed in the vitamin D and calcium supplemented group compared to the placebo group (Samimi et al., 2015) . Similarly, Asemi and Esmaillzadeh (2015) also reported positive outcomes on supplementation with vitamin D (400 IU) and multiminerals (800 mg calcium, 200 mg magnesium, 8 mg zinc) over nine weeks compared to placebo in at-risk preeclampsia patients. Recently, the published Cochrane review on vitamin D supplementation studies reported that women who receive vitamin D supplementation had lower risk of preeclampsia but with only borderline significance (RR 0.52, CI 0.25-1.05), whereas combined vitamin D and calcium supplementation significantly reduces the risk of preeclampsia (Risk Ratio (RR): 0.51, CI 0.32-0.80) (De-Regil et al., 2016) . Our analysis also supports the conclusion of Cochrane review that vitamin D supplementation reduces the risk of preeclampsia.
Gestational diabetes mellitus (GDM)
Gestational diabetes mellitus is defined as hyperglycemia from glucose intolerance that develops or is first diagnosed during pregnancy (Baz and Riveline, 2015) . Vitamin D plays a role in glucose homeostasis by multiple mechanisms (Lithy et al., 2014) . First, it regulates the calcium levels, which in turn regulates insulin production and secretion by the endocrine pancreas (Al-Shoumer and Al-essa, 2015) . It also improves the sensitivity of the target cells like adipose tissue, liver, and skeletal muscles to insulin (Lithy et al., 2014) . Through its role in regulation of immune cells, it protects b cells from detrimental immune attacks and even enhances their function (Al-Shoumer and Al-essa, 2015). Vitamin D deficiency or the dysfunction of vitamin D receptors relates to the pathogenesis of type 1 and type 2 diabetes, but its role in GDM remains inconclusive.
Eight observational studies have been recently conducted to study the association of vitamin D with GDM. Arnold et al. (2015) conducted a nested case-control study in the United States among pregnant women and reported an inverse relationship between vitamin D status in early pregnancy and risk of gestational diabetes. A 5 ng/ml increase in vitamin D3 levels was associated with reduction in GDM risk by 14%. Similar effects were reported by Lacroix and Myriam (2014) in a prospective observational study in Canada and by Lithy et al. (2014) in a cross-sectional observational study in Arab women. On the contrary, multiple studies failed to establish a role of vitamin D in the prevention of GDM (Schneuer et al., 2014; Sunmin et al., 2014; Whitelaw et al., 2014; Flood-nichols et al., 2015; Loy et al., 2015) . The lack of consistent findings calls for large-scale prospective studies to evaluate the role of vitamin D in GDM.
To test the effectiveness of vitamin D supplementation in the prevention or reduction of risk of GDM, many randomized controlled clinical trials have been conducted. Six RCTs have been conducted in this regard from January 2014 onward (Asemi et al., 2013 (Asemi et al., , 2014 Hossain et al., 2014; Yap et al., 2014; Mojibian et al., 2015; Sablok et al., 2015) . Asemi et al. (2014) performed a randomized placebo controlled trial in Iranian pregnant women and found positive impact of vitamin D and calcium supplementation on the metabolic profiles of GDM patient with decrease in free plasma glucose, serum insulin, HOMA-IR, LDL cholesterol, and total cholesterol. Few other studies, on the contrary, reported no beneficial effects of vitamin D supplementation on GDM outcome (Hossain et al., 2014; Sablok et al., 2015) . To compare and contrast the efficacy of different dosing patterns of vitamin D on GDM, recently two clinical trials were undertaken; Yap et al. (2014) conducted the study in women with 25OHD levels less than 32 ng/ml before 20 weeks and randomized them to receive oral vitamin D3 at 5000 IU daily or 400 IU daily from 14 weeks until delivery, and found no difference in the outcomes. Mojibian et al. (2015) randomized pregnant women with 25OHD less than 30 ng/ml to receive 400 IU daily or 50,000 IU every two weeks until delivery, and found improved outcomes with high dose vitamin D supplementation. The difference in the outcomes could be attributed to different dosages of vitamin D used for intervention, as well as the varying dosing schedules in the two studies. Two recently published meta-analyses of RCTs (P erez-L opez et al., 2015; De-Regil et al., 2016), however, showed same incidence of GDM with and without vitamin D supplementation. While studies have shown varying results, the overall level of evidence is high for vitamin D supplementation playing no role in the prevention of GDM.
Cesarean section (C-section)
Vitamin D receptors are present on smooth muscle cells, including uterine muscles, and skeletal muscle cells. Vitamin D regulates the contractile proteins of uterine myometrial cells (Loy et al., 2015) . Vitamin D deficiency, therefore, may decrease the strength of the contractile muscles, causing prolonged labor or obstructed labor, indicating the need for C-section (Sebastian et al., 2015) . Vitamin D deficiency has also been postulated to cause malformation of pelvis, which is yet another indication for C-section . Few studies have analyzed the association between vitamin D levels and cesarean sections. Recently, five observational studies were conducted with mixed outcomes Loy et al., 2015; Rodriguez et al., 2015; Sebastian et al., 2015) . In a prospective cohort study conducted in Spain in 2382 motherchild pairs, Rodriguez et al. (2015) reported that adequate vitamin D (25 OHD 30 ng/ml) decreased the risk of C-section by obstructed labor (RR D 0.60, 95% CI 0.37, 0.97). In a multiethnic Asian cohort study conducted by GUSTO study group (Loy et al., 2015) , it was found that low vitamin D levels were associated with increased risk of emergency C-sections in Chinese and Indian women, and not in Malay women and overall there was no significant association. No association between vitamin D deficiency and risk of C-section was reported in other recent studies Sebastian et al., 2015) . The inconsistency in the findings might be due to the difference in defining C-section in terms of indication, primary or secondary, emergency or elective .
There have not been any interventional studies undertaken to determine the association between the two. Although analysis of the recent observational studies suggests that vitamin D deficiency can increase the risk of C section, there is a need for investigators to conduct RCTs to study the impact of vitamin D supplementation on C-section rates.
Preterm delivery
One of the most common causes for preterm delivery is infection (Sangkomkamhang et al., 2015) . Vitamin D, through its role in anti-inflammatory pathways via nuclear factor-kB inhibition, could play a role in decreasing the incidence of infections thereby, preterm births (Thota et al., 2014) . But the exact role of vitamin D in the pathogenesis of preterm birth has not yet been clearly defined. Five observational and four interventional studies have investigated their association with lack of consistency in the results. Bodnar et al. (2015) conducted a case-control study with 1126 cases and 2327 controls in Pittsburgh, PA, USA. Serum 25OHD was measured using liquid chromatography-tandem mass spectroscopy and a protective association of vitamin D sufficiency and preterm birth was found after adjusting confounding factors. Thota et al. (2014) reported similar results. However, other studies did not support the above findings (Schneuer et al., 2014; Wetta et al., 2014; Rodriguez et al., 2015) .
Few recent interventional studies on vitamin D supplementation examined its role in the prevention of preterm births. Hossain et al. (2014) carried out an RCT of routine care (200 mg ferrous sulfate and 600 mg calcium) vs. vitamin D3 supplementation (4000 IU daily) from 20 weeks of gestation till delivery in 207 pregnant women and reported comparable outcomes in both the groups (p >0.05). Mojibian et al. (2015) also reported similar findings. On the contrary, Sablok et al. (2015) found decreased incidence of preterm delivery in the group with vitamin D supplementation (8.3%) compared to no intervention (21.1%) though it was not statistically significant. Wagner et al. (2015) carried out a post hoc analysis to measure the strength of association between serum 25OHD levels at three times, one in each trimester and preterm birth. They found that maternal vitamin D status closest to the delivery was most significantly associated with preterm birth, thereby proposing that later intervention could be used as a rescue treatment to decrease the risk of preterm deliveries (Wagner et al., 2015) . Meta-analysis carried out by P erez-L opez et al. (2015) showed no significant impact of vitamin D supplementation on the prevention of preterm deliveries. Though the level of evidence is moderate, our analysis shows no significant association between vitamin D and preterm deliveries.
Recurrent pregnancy loss
One of the non-classical functions of vitamin D is the regulation of immune system. To maintain maternal fetal interaction for a successful pregnancy, a dominant Th2 cell response is required (Garrido-gimenez and Alijotas-reig, 2015) . Therefore, dysregulated immune function and autoimmunity could alter the immune response leading to pregnancy loss. Vitamin D reportedly inhibits Th1 cells-mediated immune response and also the production of their cytokines, including IFN-Y, IL-2, and TNF-a, while promoting the proliferation of Th2 cells and their cytokines, including IL-4, IL-5, IL-6, IL-9, IL-13 (Wei and Christakos, 2015) . Such an effect of vitamin D supports its role in the immunoregulation during implantation. This hypothesis was examined by Ota et al. (2014) who conducted a retrospective study of 133 pregnant women with a history of three or more pregnancy loss before 20 weeks of gestation. Serum vitamin D levels and the markers of immunity were measured. The 47.4% of these women had low vitamin D levels (<30 ng/ml). The levels of autoantibodies were significantly higher in vitamin D-deficient group. These include anti-phospholipid antibody (APA) (p < 0.005, adjusted OR 2.22, CI 1.0-4.7), antinuclear antigen antibody, anti-ssDNA and thyroperoxidase antibody. This was also followed by in vitro experiments and significantly decreased ratio of TNF-a/IL-10 expressing CD3C/ CD4C cells with 100 nM of vitamin D3 (31.3 § 9.4 ng/ml, p < 0.05) was found in cases compared to controls (40.4 § 11.3 ng/ ml). Although no conclusion can be drawn based on the findings of a single study, but this calls for more observational and interventional studies to establish the association between the two.
Postpartum depression
Postpartum depression is the most common psychiatric condition occurring in the postpartum period (Cherry et al., 2014) . Vitamin D is believed to be a neurosteroid and has been linked to the occurrence of depression (Anglin et al., 2013) . There are various plausible mechanisms relating postpartum depression with vitamin D deficiency. First, VDRs are located throughout the body including brain, so, in case of vitamin D-deficiency, the VDRs in the brain may affect the hormones that are involved in the occurrence of mood disorders . Vitamin D also plays a role in brain processes like neurotransmission, neuro-immunomodulation, and neuroprotection (Christesen et al., 2012) . Third, vitamin D is involved in the synthesis of norepinephrine and dopamine, which gets imbalanced in mood disorders (Eyles et al., 2013) . Additionally, vitamin D maintains the antioxidant glutathione in brain, thereby protecting brain from oxidative damage. Lastly, VDRs are present in the areas of brain involved in planning, processing, and formation of new memories (Eyles et al., 2013) .
Many studies have been designed to investigate an association between postpartum depression and vitamin D. Recently, four observational studies were performed in this regard. Fu et al. (2015) conducted a prospective cohort study in 248 pregnant women in China to examine an association between serum vitamin D levels 24 hours after delivery and postpartum depression. The investigators reported that serum 25OHD levels were significantly higher in women with no postpartum depression (p < 0.001). After adjusting for confounders and using multivariate analysis, they found increased risk of postpartum depression with 25OHD levels 10.2 ng/ml (OR 7.17, CI 3.81-12.94, p < 0.001). Gur et al. (2015) reported a significant association between mid-pregnancy vitamin D levels and postpartum depression. They conducted this study in 678 Turkish pregnant women, measured serum 25OHD level between 24 and 28 weeks of gestation and then assessed these women for postpartum depression using Edinburgh Postnatal Depression Scale (EPDS) at one week, six weeks, and six months postpartum. The investigators also found significant negative correlation between vitamin D levels and EDPS at all the three follow-up periods (r D ¡0.2, ¡0.2, ¡0.3, respectively). Robinson et al. (2014) also demonstrated a positive association between vitamin D deficiency and postpartum depression. On the contrary, Gould et al. (2015) performed a similar study on a large cohort of 1040 women in Australia. They measured cord blood 25OHD and then evaluated these women for postpartum depression symptoms using EPDS at six weeks and six months postpartum. They reported no association between cord blood vitamin D levels and postpartum depression. Although the results from various studies are conflicting, postpartum depression might be associated with vitamin D deficiency but the studies have been inconsistent in their results and warrant more extensive studies in this regard.
Adverse fetal outcomes associated with vitamin D deficiency
Low birth weight (LBW) and small for gestational age (SGA) Vitamin D plays a role in fetal growth by regulating calcium homeostasis and parathyroid hormone levels (Hollis et al., 2011) . Maternal vitamin D adequacy improves the fetal outcomes in the form of birth weight sufficiency that has been proven by many but not all studies. Most of them are observational studies. In our search, we found nine studies that reported this correlation; three were cross-sectional studies, three were case-control studies, and three were prospective cohorts. Chen et al. (2015) performed a population-based cohort, recruiting 3658 mother-fetus pairs. Maternal serum 25OHD level was measured at any time during pregnancy. A positive correlation was found between maternal 25OHD levels and neonatal birth weight (r D 0.477, p < 0.001). Similar results were reported by other investigators (Gernand et al., 2014; Khalessi et al., 2015; Mirzaei et al., 2015; Aydogmus et al., 2015; Morgan et al., 2016) . Another study undertaken in China by Zhu et al. (2015) measured the cord blood 25OHD levels and its association with low birth weight and SGA in 1491 neonates. They reported that per 10 nmol/l increase in the cord blood 25OHD level, birth weight increased by 61.0 g at concentration less than 40 nmol/l of 25OHD, and then decreased by 68.5 g at concentrations from 40 to 70 nmol/l. This is the first study to report inverted U-shaped relationship between neonatal vitamin D status and fetal growth. However, other studies failed to establish any association between vitamin D levels and fetal birth weight (Schneuer et al., 2014; Rodriguez et al., 2015) . Conflicting results were found in the interventional studies for vitamin D supplementation and its impact on offspring birth weight. One of these studies conducted by Mojibian et al. (2015) in Iranian pregnant women found no difference on vitamin D supplementation on the fetal outcomes. Another RCT carried out by Hossain et al. (2014) found improved outcomes with vitamin D supplementation, but the results did not reach statistical significance. Thus, most of the findings suggest that vitamin D deficiency increases the risk of low birth weight infants. However, large-scale well-designed interventional studies are required to further establish the role of vitamin D supplementation to improve fetal outcomes.
Respiratory infections
Vitamin D receptors (VDRs) are present on almost every immune cells, and activation of VDRs plays a critical role in adaptive and innate immunity, along with the regulation of inflammatory response (Esposito and Lelii, 2015) . There are multiple mechanisms by which vitamin D could regulate inflammatory response: (i) vitamin D controls the activity of macrophages and dendritic cells and various events in response to the activation of Toll-like receptors in neutrophils (Greiller and Martineau, 2015) , (ii) vitamin D inhibits the function of dendritic cells by restricting their maturation, antigen presentation, and the production of cytokines, like IL-12 and IL-23 (Esposito and Lelii, 2015) , (iii) vitamin D induces the expression of two antimicrobial peptides, cathelicidin and b-defensin, which are critical in innate immunity through chemotactic action and neutralization of toxins (S a et al., 2015) , and (iv) vitamin D shifts the cytokine expression from type 1 to type 2 cells response, thus contributing to the maintenance of self-tolerance (Wei and Christakos, 2015) . Thus, based on the potent immunomodulatory effect of vitamin D, several studies have linked vitamin D deficiency to the increased risk of respiratory tract infections in children. It has been hypothesized that maternal vitamin D deficiency increases the risk of respiratory tract infections in their offspring. Few investigators recently studied this association. Five observational studies have been conducted. Onwuneme et al. (2015) performed a study in 94 preterm infants and found that low serum 25OHD levels (<30 nmol/l) in pre-terms were associated with increased oxygen requirements (p D 0.008), increased duration of intermittent positive pressure ventilation (p D 0.032), and more requirement of assisted ventilation (p D 0.013). Luczynska et al. (2014) performed a prospective cohort study on 777 mother-child pairs in Germany and found a statistically significant association between 25OHD levels in cord blood and susceptibility to lower respiratory tract infection (LRTI). The adjusted risk-ratio for vitamin D deficient infants (<25 nmol/l) was 1.32 in comparison to the reference group (>50 nmol/l). In Turkey, Dinlen et al. (2016) reported the same conclusions. They performed a study in 60 infants, 30 with acute LRTI term infants and 30 controls matched for gestational age, weight, and gender and reported lower serum 25OHD levels in mothers of the study group (p D 0.0001). However, Jongh et al. (2014) reported no association between the two based on a cohort study performed on 2025 mother-child pairs in Southampton, UK with mother's serum 25OHD measured at 34 weeks' gestation and infants followed up at 6, 12, and 24 months for respiratory symptoms. In summary, maternal vitamin D deficiency can increase the risk of respiratory infections in infants. This conclusion is yet to be confirmed by interventional studies.
Immunity and allergies
As mentioned earlier, Vitamin D plays an important role in the immunomodulation through its effect on the function of T and B lymphocytes. While in T cells, it promotes Th2 cell-mediated anti-inflammatory response, in B cells vitamin D promotes the production of immunoglobulins and inhibition of memory B cells and generation of plasma cells (Szymczak and Pawliczak, 2016) .
To validate the association between maternal vitamin D status and development of allergies, including eczema and asthma in their offspring, recently four observational studies and two interventional studies have been carried out. In Taiwan, a study was conducted in 164 mother-child pairs cohort to study this association (Chiu et al., 2015) and reported protective effect of vitamin D in protecting children from allergies, eczema, and asthma after following-up children for up to four years of age. Maslova et al. (2014) conducted a prospective cohort study in Denmark in 965 pregnant women and their offspring were followed until adulthood for airway allergic diseases and lung function. In this study, higher levels of maternal vitamin D 125 nmol/l was found to be associated with higher incidence of allergies in children (Hazard Ratio, HR D 1.81, 95% CI D 0.78-4.16). In UK, Miller et al. (2015) studied the association between maternal vitamin D and neonatal inflammatory and allergic response by studying the response of neonatal nasal airway epithelial cells (AECs). They reported that increased maternal vitamin D was associated with increased release of IL-10 by AECs after stimulation with TNF-a/IL-1b (p D 0.024) or house dust mite (p D 0.049). It was concluded that there exists an association between maternal micronutrient intake and the function of neonatal airway cells and hence may impact the development of asthma or allergies later in life. Jones et al. (2015) selected a cohort of mothers with history of atopy and investigated the association of vitamin D in them to the immune response in their children and found that improving serum 25OHD level during pregnancy or early infancy can lower the risk of allergies by inhibiting the inflammatory cytokines associated with allergies.
This association has been of interest for carrying out interventional studies as well. Vitamin D Antenatal Asthma Reduction Trial (VDAART; Litonjua et al., 2016) was a randomized, double blind, placebo-controlled trial conducted across three centers in the United States. A total of 881 pregnant women at 10-18 weeks' gestation at high risk of having children with asthma were included in the study. They reported that the risk of asthma and wheeze-related disorders were lower in vitamin D supplemented women by 6.1% compared to the placebo group, although it did not reach statistical significance. Another interventional study took place in Japan (Norizoe et al., 2014) , which studied the impact of maternal vitamin D supplementation during lactation to improve the outcomes in infantile allergic disorders like eczema. They concluded that although vitamin D supplementation did not decrease the incidence of eczema, but it enhanced the risk of food allergies up to two years of age (RR 3.42, 95% CI: 1.02-11.77; p D 0.030). In conclusion, there is still no definite evidence of whether vitamin D supplementation increases or decreases the risk of allergies and therefore, requires further exploration.
Anthropometry
Vitamin D plays a primary role in bone remodeling, calcium homeostasis, and muscle functioning. Its deficiency in pregnancy is associated with impaired bone development, fetal growth, and other unfavorable effects on musculoskeletal system of the offspring (Kovacs, 2014) .
Some studies have shown adverse effects of maternal vitamin D deficiency on the anthropometric measures of the offspring. This includes one cohort study (Morales et al., 2015) and four RCTs (Hashemipour et al., 2013; Hossain et al., 2014; Nandal et al., 2015; Roth et al., 2015) . Morales et al. (2015) conducted a study in a cohort of 2358 pregnant women in Spain and measured serum 25OHD levels at any time during gestation. Child's femur length, bi-parietal diameter, and abdominal circumference were noted through ultrasound findings at 12, 20, and 34 weeks of gestation. They found no association of maternal serum 25OHD level with femur length and a weak inverse association with bi-parietal diameter at 34 weeks.
A single center randomized clinical trial in Pakistan reported no favorable outcomes on fetal growth by vitamin D supplementation (Hossain et al., 2014) . Nandal et al. (2015) conducted a case-control study of 120 pregnant women in India and found that the women's offspring supplemented with vitamin D had higher birth weight and crown heel length compared to the non-supplemented group (3.1 § 0.485 kg vs. 2.8 § 0.705 kg and 49.35 § 1.36 cm vs. 48.67 § 2.12 cm, respectively). Similarly, Hashemipour et al. (2013) conducted a randomized controlled trial in 130 Iranian pregnant women and reported that mean length (p D 0.01), head circumference (p D 0.001), and weight (p D 0.01) were higher in the intervention group compared to the control group. There is an ongoing trial in Dhaka, Bangladesh to estimate the effects of prenatal and postnatal supplementation of different doses of vitamin D vs. placebo on infant length at one year of age (Roth et al., 2015) . In this study, healthy pregnant women in second trimester have been randomized to receive either vitamin D 4200 IU/ week, 16,800 IU/week, or 28,000 IU/week and placebo in the postpartum period or 28,000 IU/week in the prenatal and postpartum period, and the infants will be followed up at regular intervals for growth monitoring up to one year of age. A recently published meta-analysis of RCTs by P erez-L opez et al.
(2015) also concludes positive outcomes of vitamin D supplementation in pregnancy on offspring birth weight and length. Thus, our analysis of the published findings also supports that vitamin D supplementation in pregnancy has a positive impact on fetal growth.
Vitamin D and autism
A recent meta-analysis by Wang et al. (2015) investigated the possible mechanisms by which vitamin D could potentially influence the occurrence of autism spectrum disorders in children. First, it influences the early brain development in children. It plays a role in neuronal differentiation, neurotransmission, and synaptic functions . Second, as vitamin D is involved in the immune system homeostasis and autism is considered an autoimmune disorder, so it is considered that vitamin D deficiency may alter T cell activation profile and affect the adaptive immunity and cause preponderance to autism (Currenti, 2010) . Also, oxidative stress may increase the susceptibility to autism by their lethal interaction with genetically susceptible genes. Glutathione is an antioxidant that protects the brain from the oxidative stress and vitamin D increases the level of glutathione in the brain, thereby protecting it from preventable conditions like autism (Cannell, 2008) . Serotonin plays an essential role in controlling emotions. Vitamin D activates the serotonin-synthesizing gene in the brain and inversely affects the serotonin production in peripheral tissues (Patrick and Ames, 2014) . It is seen that autistic individuals have lower concentration of serotonin in brain and higher in their blood, indicating that vitamin D could be potentially involved in the underlying pathogenesis. Lastly, vitamin D deficiency could increase the risk of genetic mutations by inhibiting DNA repair of early mutations, and thus could contribute to the appearance of autism .
An interventional study recently reviewed the benefits of vitamin D supplementation in pregnant women to decrease the incidence of autism in the offspring. This was conducted by Stubbs et al. (2016) whereby the investigators supplemented pregnant women with previous autistic child, with 5000 IU/day of vitamin D followed by supplementation of newborn with 1000 IU/day vitamin D for first three years of life. These children were followed up at 18 and 36 months of age. The results were promising, with only 1 out of 19 children developing autism (5%), compared to the general recurrence risk of 20%. This single recent study suggests that vitamin D supplementation in pregnancy could reduce the risk of autism in children, but more studies are warranted to confirm the conclusion.
Conclusion
Vitamin D deficiency is increasing worldwide, both in general population and in pregnant women. In pregnancy, it has been found to be associated with increased incidence of adverse maternal and fetal outcomes, primarily preeclampsia, GDM, low birth weight, and preterm births. Other outcomes are still under study and no definite conclusions have been drawn yet. The critical evaluation of the published findings on the maternal and fetal outcomes in a large number of observational studies and critical trials in a large cohort provide high level of evidence for an association between vitamin D and preeclampsia, GDM in maternal outcomes, and small for gestational age and anthropometry in fetal outcomes (Table 4 ). Other maternal-fetal outcomes have moderate level of evidence of association with vitamin D, as reported in other reports and meta analyses. In our review of the findings, we also found association between vitamin D and recurrent pregnancy loss and association between vitamin D and autism, although the level of evidence remains low, thereby requiring additional studies to confirm the association. However, the question still remains whether there is any causal relationship between vitamin D deficiency and the maternal and fetal outcomes or it is just one of the manifestations of these conditions. The etiology of the various maternal and fetal outcomes is complex and multifactorial with many confounding factors. To determine the benefits of vitamin D supplementation in pregnancy would require further evaluation through large, multicenter double-blind randomized controlled clinical trials, with a focus on specific adverse pregnancy outcomes. Additionally, dose-response randomized trials would be helpful in identifying the optimal dosage for supplementation and potential long-term side effects of vitamin D therapy.
